£30m Initiative to Tackle deadly AMR Threat : vimarsana

The UK's largest public-private initiative targeting early-stage antimicrobial drug and diagnostic discovery has been introduced by Innovate UK, LifeArc and Medicines Discovery Catapult (MDC). Click to read more...

Related Keywords

United Kingdom , Paula Sommer , Dame Sally Davies , Ron Daniels , Indro Mukerjee , Chris Molloy , Department For Science , World Bank , Head Of Research At Cystic Fibrosis , United Kingdom Sepsis , Innovate United Kingdom , Medicines Discovery Catapult , Antimicrobial Clinical Efficacy , United Kingdom Special Envoy , Antimicrobial Resistance , Life Arc , George Freeman , United Kingdom Sepsis Trust , Cystic Fibrosis Trust , Medicines Discovery , Discovery Catapult , Discovery , Race , Health , Antimicrobial , Lobal , Dash , Oday , Resistant , Infections , Resistance ,